Biological Information

Background Information:

Five subtypes of dopamine receptors, D1, D2, D3, D4 and D5, were identified on the basis of pharmacological or biochemical criteria. The D2-like receptors include the two isoforms of the D2 receptor, differing in the length of their predicted third cytoplasmic loop, dubbed D2 short (D2S) and D2 long (D2L). The dopamine D2S receptor couples to PTX-sensitive G proteins (Gi/o) to initiate multiple signaling pathways. In cells of neuroendocrine origin, the D2S couples to "inhibitory" pathways, including inhibition of adenylyl cyclase, activation of potassium channels to hyperpolarize the cell membrane, and inhibition of L-type calcium channels, which in concert mediate inhibition of hormone secretion and gene transcription, and inhibition of cell proliferation. D2 dopamine receptors have been implicated in the pathophysiology of schizophrenia and Parkinson’s disease.

Family:

GPCR

Sub Family:

Dopamine

Class:

Class A

Protein Name:

D2

Uniprot Number:

P14416

Gene Name:

DRD2

Gene ID:

1813

Organism:

Human

Assay Information

Assay Type:

Functional

Assay Sub Type:

Cell Based

Functional Mode:

Antagonist

Testing Information

Test Sample Requirements:

300uL of a 1000X stock based on the top or final concentration being tested

Turnaround Time

Standard:

20 Business Days

Service Scheduling Note:

Eurofins DiscoverX will make reasonable efforts to deliver screening data within (20) business days from the start date of the scheduled assay service provided that Materials and required documentation are received prior to run date.

Clinical Relevance

Adverse / Beneficial Action:

Dopamine D2 receptor antagonist may be used in the treatment of psychosis; may also result in tardive dyskinesia and increase pituitary hormone secretion.

Additional Information

Brand:

SafetyScreen

Testing Location:

USA - San Diego, CA